Outcomes and Risk Factors in Vasoplegic Patients Following Left Ventricular Assist Device Implantation

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Critical Care Medicine

Background:

• Vasoplegia is a significant postoperative complication following left ventricular assist device (LVAD) implantation.
• Understanding its incidence and associated factors is crucial for optimizing patient outcomes.

Purpose of the Study:

• To determine the incidence of vasoplegia in patients receiving a HeartMate LVAD.
• To identify management strategies and factors associated with vasoplegia development.
• To evaluate the impact of preoperative renin-angiotensin-aldosterone system inhibitors on vasoplegia.

Main Methods:

• Retrospective, observational study at a single academic medical center.
• Included 184 adult patients undergoing LVAD implantation between 2019 and 2022.
• Vasoplegia defined as persistent hypotension requiring high-dose norepinephrine equivalent for >6 hours.

Main Results:

• The incidence of vasoplegia was 33%.
• Independent predictors of vasoplegia included longer cardiopulmonary bypass duration, preoperative renal dysfunction, and postoperative inotrope use.
• No significant difference in vasoplegia rates was observed with preoperative renin-angiotensin-aldosterone system inhibitor use.

Conclusions:

• Vasoplegia is a frequent complication after LVAD implantation.
• Cardiopulmonary bypass duration, preoperative renal dysfunction, and postoperative inotrope use are associated with increased vasoplegia risk.
• Further research may focus on targeted interventions to mitigate these risks.